Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytarabine Protocol for Newly Diagnosed Childhood LCH
NCT04773366Phase 3Recruiting
- Start
- Jul 2018
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine in Langerhans cell histiocytosis (LCH). Started Jul 2018; status: recruiting.
02
Drugs
cytarabine
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on NCT04773366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04773366.